We spend billions searching for the cures to chronic illnesses while neglecting research that could make the daily lives of ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.

Conductor Daniel Barenboim says he has been diagnosed with Parkinson’s disease. The 82-year-old issued a statement Thursday ...

Daniel Barenboim, the eminent conductor and pianist who stepped back from engagements in recent years citing health concerns, ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's ...

Sharon Osbourne gave an update on how Parkinson’s disease has impacted husband Ozzy Osbourne’s legs as the musician prepares ...

The renowned musician says he plans to keep playing, after confirming the long-suspected diagnosis.

Osbourne is set to reunite with original bandmates Tony Iommi, Geezer Butler and Bill Ward for a farewell concert in July.

The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...